What is Med Screen Labs?
Based in New Jersey, Med Screen Labs operates as a specialized toxicology laboratory, providing essential diagnostic support to addiction treatment facilities. By delivering high-precision testing solutions, the company enables healthcare providers to make data-informed decisions in the management of substance abuse recovery. The firm has carved out a distinct market position by prioritizing rapid turnaround times and clinical accuracy, which are vital components for facilities navigating the complexities of patient care and regulatory compliance. As a key player in the diagnostic services sector, Med Screen Labs serves as a foundational partner for institutions dedicated to combating the ongoing substance abuse crisis through evidence-based monitoring.
How much funding has Med Screen Labs raised?
Med Screen Labs has raised a total of $333K across 1 funding round:
Debt
$333K
Debt (2021): $333K with participation from PPP
Key Investors in Med Screen Labs
PPP
Public-Private Partnership
What's next for Med Screen Labs?
With the successful closure of this late-stage funding, Med Screen Labs is poised to scale its operational capacity and enhance its technological footprint. The strategic allocation of this capital will likely focus on expanding laboratory throughput, integrating advanced diagnostic automation, and strengthening its service network across the healthcare landscape. By leveraging this financial backing, the company aims to deepen its market penetration and improve the efficacy of its toxicology reporting, ultimately driving better patient outcomes. Future growth initiatives will likely center on optimizing supply chain logistics and potentially exploring new diagnostic modalities that align with the evolving needs of addiction treatment centers, ensuring the firm remains at the forefront of clinical toxicology innovation.
See full Med Screen Labs company page
